• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[持续性腹膜透析中的临床化学参数]

[Clinical chemistry parameters in continuous peritoneal dialysis].

作者信息

Jung N, Karátson A, Thieler H, Baufeld A, Schmidt U

出版信息

Z Gesamte Inn Med. 1980 Feb 1;35(3):123-6.

PMID:7395293
Abstract

The continuous peritoneal dialysis (CAPD) is with four or five change of 1 1/2-2 l dialysis solution a day a 24 hours/day and 7 days/week dialysis. In 6 patients with terminal renal insufficiency the behaviour of biochemical parameters which serve as acknowledged indicators for the efficiency of a dialysis technique, were pursued under this method more than 4 weeks. At the end of the treatment period the following average values came up: creatinine 9.0 mg/dl, urea-N 65 mg/dl, anorganic phosphate 4.8 mg/dl (without Al-hydroxide), potassium 4.3 mval/l, calcium 4.1 mval/l and a pH-value of 7.35. The results allow the conclusion that with the CAPD a sufficient elimination of retention products is possible and values in the suburaemic region may be achieved similar to the conditions in the intermittent dialytic technique. Conclusions concerning a broad application of the technique in the terminal renal insufficiency may, however, not be made alone from these observations, since the problems of relapsing peritonitis and of the chronic loss of protein known from literature did not yet play a role in our patients in the short observation period.

摘要

持续性非卧床腹膜透析(CAPD)是每天进行4至5次1.5至2升透析液的更换,每周7天、每天24小时进行透析。对6例终末期肾功能不全患者采用该方法进行了4周以上的观察,追踪了作为公认的透析技术效率指标的生化参数变化情况。在治疗期末得到了以下平均值:肌酐9.0毫克/分升,尿素氮65毫克/分升,无机磷4.8毫克/分升(未服用氢氧化铝时),钾4.3毫当量/升,钙4.1毫当量/升,pH值7.35。这些结果表明,采用CAPD能够充分清除潴留产物,并且可以达到与间歇性透析技术类似的亚尿毒症区域数值。然而,仅根据这些观察结果尚不能得出该技术可广泛应用于终末期肾功能不全的结论,因为在短观察期内,文献中已知的复发性腹膜炎和慢性蛋白质丢失问题在我们的患者中尚未出现。

相似文献

1
[Clinical chemistry parameters in continuous peritoneal dialysis].[持续性腹膜透析中的临床化学参数]
Z Gesamte Inn Med. 1980 Feb 1;35(3):123-6.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.
Proc Eur Dial Transplant Assoc. 1979;16:171-7.
4
Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.同一患者间歇性与持续性非卧床腹膜透析的纵向比较。
Clin Nephrol. 1981 Dec;16(6):293-9.
5
Polyglucose dialysis solution induces changes in blood chemistry.聚葡萄糖透析液会引起血液化学成分的变化。
Adv Perit Dial. 2001;17:101-8.
6
[Chronic ambulatory peritoneal dialysis].[慢性非卧床腹膜透析]
Schweiz Med Wochenschr. 1981 Aug 22;111(34):1232-8.
7
[Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].[腹膜透析中磷控制的影响因素。治疗选择]
Nefrologia. 2000 Jul-Aug;20(4):355-61.
8
Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.在接受重组人促红细胞生成素治疗的持续性非卧床腹膜透析或持续性循环腹膜透析患者中使用大剂量腹腔内右旋糖酐铁。
Adv Perit Dial. 1999;15:60-4.
9
The effects of increasing exchange volume and frequency on peritoneal dialysis adequacy.增加交换量和频率对腹膜透析充分性的影响。
Clin Nephrol. 1998 Dec;50(6):375-80.
10
[Clinical experiences with nocturnal intermittent peritoneal dialysis].
Dtsch Med Wochenschr. 1993 Jan 12;118(1-2):6-12. doi: 10.1055/s-2008-1059294.